Lou; Zhenkun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lou; Zhenkun.The latest application filed is for "methods and materials for identifying and treating cancers having elevated levels of phosphorylated ubiquitin".

Company Profile

9.8.15

Lou; Zhenkun - Rochester MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
HEATR1 as a marker for chemoresistance Grant 11,371,099 - Lou , et al. June 28, 2	2022-06-28
Methods And Materials For Identifying And Treating Cancers Having Elevated Levels Of Phosphorylated Ubiquitin App 20210373023 - Lou; Zhenkun ; et al.	2021-12-02
Methods and materials for treating cancer Grant 11,136,583 - Lou , et al. October 5, 2	2021-10-05
Methods And Materials For Treating Cancer App 20200338112 - Lou; Zhenkun ; et al.	2020-10-29
Methods And Materials For Treating Cancer App 20200323860 - Lou; Zhenkun ; et al.	2020-10-15
Method of treating cancer metastasis by CDK 4/6 inhibitors Grant 10,690,673 - Lou , et al.	2020-06-23
Targeting WSB1 and pVHL to treat cancer Grant 10,526,606 - Lou , et al. J	2020-01-07
Methods And Materials For Treating Cancer App 20190330638 - Lou; Zhenkun ; et al.	2019-10-31
Treating Cancer Metastasis App 20190120844 - Lou; Zhenkun ; et al.	2019-04-25
Methods And Materials For Modulating Deubiquitinases And Ubiquitinated Polypeptides App 20190105377 - Lou; Zhenkun ; et al.	2019-04-11
Usp10 Modulation Of Ampk And Mtor App 20190030139 - LOU; Zhenkun ; et al.	2019-01-31
TARGETING WSB1 AND pVHL TO TREAT CANCER App 20190010501 - Lou; Zhenkun ; et al.	2019-01-10
Heatr1 As A Marker For Chemoresistance App 20180346991 - LIU; Tongzheng ; et al.	2018-12-06
Methods And Materials For Treating Cancer App 20180344736 - Lou; Zhenkun ; et al.	2018-12-06
Methods and materials for treating cancers that express reduced levels of wild-type p53 polypeptides Grant 10,137,174 - Lou , et al. November 27, 2	2018-11-27
Targeting WSB1 and pVHL to treat cancer Grant 10,093,930 - Lou , et al. October 9, 2	2018-10-09
Methods And Materials For Treating Cancer App 20180200261 - Deng; Min ; et al.	2018-07-19
TARGETING WSB1 AND pVHL TO TREAT CANCER App 20160326532 - Lou; Zhenkun	2016-11-10
Methods And Materials For Modulating Deubiquitinases And Ubiquitinated Polypeptides App 20160136248 - Lou; Zhenkun ; et al.	2016-05-19
Methods And Materials For Modulating Deubiquitinases And Ubiquitinated Polypeptides App 20140315741 - Lou; Zhenkun ; et al.	2014-10-23
Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides Grant 8,853,180 - Lou , et al. October 7, 2	2014-10-07
Methods And Materials For Modulating Deubiquitinases And Ubiquitinated Polypeptides App 20120171192 - Lou; Zhenkun ; et al.	2012-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.